10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q1 2017

Filing Information

Form Type	10-Q
Accession Number	`0001493152-17-005355`
Period End Date	20170331
Filing Date	20170515
Fiscal Year	2017
Fiscal Period	Q1
XBRL Instance	heb-20170331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 32 Cash Flow Statement 54 Stockholders Equity 10

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.41M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.01M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$776.00K	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$3.46M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$2.97M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$41.00K	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	$764.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	$764.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	26.19M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	24.20M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$309.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$636.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	26.19M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$6.94M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	24.20M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$5.19M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.26M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.51M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$872.00K	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$870.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.55M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.55M	USD	Point-in-time
Total assets	`Assets`	$18.87M	USD	Point-in-time
Total assets	`Assets`	$16.86M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$887.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$927.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.71M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.55M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.64M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.44M	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$1.28M	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$940.00K	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 26,186,998 and 24,202,921, respectively	`CommonStockValue`	$24.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 26,186,998 and 24,202,921, respectively	`CommonStockValue`	$26.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$315.98M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$316.24M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$6.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-5.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-300.50M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-303.32M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.50M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$18.87M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$16.86M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`SalesRevenueNet`	$39.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$84.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$268.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$270.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.39M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.00M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.66M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.45M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$3.33M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$3.72M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.68M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.24M	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$61.00K	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$26.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-393.00K	USD	1 Quarter
Gain (loss) on sales of short term marketable securities	`MarketableSecuritiesGainLoss`	$1.00K	USD	1 Quarter
Gain (loss) on sales of short term marketable securities	`MarketableSecuritiesGainLoss`	$-107.00K	USD	1 Quarter
Gain from sale of income tax net operating losses and research credits	`GainFromSaleOfIncomeTaxNetOperatingLossesAndResearchCredits`	$1.56M	USD	1 Quarter
Gain from sale of income tax net operating losses and research credits	`GainFromSaleOfIncomeTaxNetOperatingLossesAndResearchCredits`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.16M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.82M	USD	1 Quarter
Reclassification adjustments for loss on sales of short term marketable securities included in net loss	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.00K	USD	1 Quarter
Reclassification adjustments for loss on sales of short term marketable securities included in net loss	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$107.00K	USD	1 Quarter
Unrealized gain on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$40.00K	USD	1 Quarter
Unrealized gain on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$12.00K	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-2.02M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-2.81M	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.10	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.11	USD	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	20.63M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	25.34M	shares	1 Quarter

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.16M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.82M	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$261.00K	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$300.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-393.00K	USD	1 Quarter
Amortization and abandonment of patent and trademark rights	`AmortizationAndAbandonmentOfIntagibleAssets`	$30.00K	USD	1 Quarter
Amortization and abandonment of patent and trademark rights	`AmortizationAndAbandonmentOfIntagibleAssets`	$13.00K	USD	1 Quarter
Equity-based compensation	`StockOptionPlanExpense`	$52.00K	USD	1 Quarter
Equity-based compensation	`StockOptionPlanExpense`	$52.00K	USD	1 Quarter
Realized loss on sale of marketable securities	`MarketableSecuritiesRealizedGainLoss`	$1.00K	USD	1 Quarter
Realized loss on sale of marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-107.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$41.00K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$327.00K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$28.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$103.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$182.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$478.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$161.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.04M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.99M	USD	1 Quarter
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	1 Quarter
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$500.00K	USD	1 Quarter
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.00K	USD	1 Quarter
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Lease deposit refund	`LeaseDepositRefund`	-	USD	1 Quarter
Lease deposit refund	`LeaseDepositRefund`	$2.00K	USD	1 Quarter
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$62.00K	USD	1 Quarter
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$11.00K	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-60.00K	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$486.00K	USD	1 Quarter
Payments on capital leases	`PaymentsOnCapitalLeases`	-	USD	1 Quarter
Payments on capital leases	`PaymentsOnCapitalLeases`	$1.00K	USD	1 Quarter
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$2.00K	USD	1 Quarter
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$875.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$875.00K	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.10M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.63M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.41M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.01M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$776.00K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.41M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.01M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$776.00K	USD	Point-in-time
Unrealized gain on marketable securities	`UnrealizedGainLossOnSecurities`	$12.00K	USD	1 Quarter
Unrealized gain on marketable securities	`UnrealizedGainLossOnSecurities`	$147.00K	USD	1 Quarter
Stock issued for accounts payable	`StockIssued1`	-	USD	1 Quarter
Stock issued for accounts payable	`StockIssued1`	$67.00K	USD	1 Quarter
Fair value of redeemable warrants granted	`FairValueOfRedeemableWarrants`	$734.00K	USD	1 Quarter
Fair value of redeemable warrants granted	`FairValueOfRedeemableWarrants`	-	USD	1 Quarter

Stockholders Equity 10 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$12.95M	USD	Point-in-time
Balance	`StockholdersEquity`	$15.50M	USD	Point-in-time
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$52.00K	USD	1 Quarter
Redeemable warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$734.00K	USD	1 Quarter
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$875.00K	USD	1 Quarter
Stock issued for accounts payable	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$67.00K	USD	1 Quarter
Net comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-2.02M	USD	1 Quarter
Net comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-2.81M	USD	1 Quarter
Balance	`StockholdersEquity`	$12.95M	USD	Point-in-time
Balance	`StockholdersEquity`	$15.50M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.